Laporan Laba Rugi CPRX - TTM - Catalyst Pharmaceuticals, Inc.

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Catalyst Pharmaceuticals, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	118	119	120	127	134	141	154	170	192	214	256	303	348	398	411	434	460	492	535	558
Change (%)		0.76	0.90	5.63	5.23	5.46	9.15	10.90	12.49	11.71	19.74	18.12	15.00	14.30	3.30	5.62	5.99	6.79	8.73	4.46
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	35	34	33	33	36	39	40	43	51	54	58	63	143	145	147	149	74	81	88	95
Change (%)		-4.72	-2.05	1.54	6.50	9.28	4.13	6.51	18.99	5.75	7.78	7.49	127.22	1.75	1.10	1.63	-50.48	10.37	8.22	7.46
% of Revenue	29.78	28.16	27.34	26.28	26.60	27.56	26.30	25.26	26.72	25.29	22.77	20.72	40.94	36.44	35.67	34.32	16.03	16.57	16.50	16.97

Gross Operating Profit	83	86	87	94	98	102	113	127	141	160	198	240	206	253	265	285	387	410	446	464
Change (%)		3.08	2.05	7.17	4.78	4.08	11.06	12.46	10.29	13.88	23.79	21.25	-14.33	23.00	4.56	7.84	35.49	6.10	8.83	3.87
% of Revenue	70.22	71.84	72.66	73.72	73.40	72.44	73.70	74.74	73.28	74.71	77.23	79.28	59.06	63.56	64.33	65.68	83.97	83.43	83.50	83.03

SG&A	42	44	47	48	50	50	53	55	56	57	70	86	106	134	151	163	176	178	178	183
Change (%)		4.60	6.00	1.49	4.56	-0.25	7.48	2.60	2.73	1.53	23.28	21.99	23.19	26.43	12.88	8.17	7.55	1.23	-0.02	2.94
% of Revenue	35.78	37.15	39.03	37.50	37.26	35.24	34.70	32.11	29.32	26.65	27.44	28.34	30.36	33.58	36.69	37.58	38.13	36.15	33.24	32.75

R&D
Change (%)
% of Revenue

OpEx	77	78	80	81	85	88	94	98	108	112	136	165	272	311	333	349	287	297	303	315
Change (%)		0.36	2.53	1.51	5.36	3.72	6.01	4.28	10.42	4.06	21.39	20.78	65.40	14.28	6.94	4.68	-17.81	3.53	2.25	3.89
% of Revenue	65.57	65.31	66.37	63.78	63.86	62.80	61.00	57.36	56.31	52.46	53.18	54.38	78.21	78.20	80.96	80.23	62.22	60.32	56.73	56.42

Operating Income	41	41	40	46	48	52	60	73	84	102	120	138	76	87	78	86	174	195	231	243
Change (%)		1.50	-2.18	13.75	5.00	8.55	14.44	21.24	15.27	21.56	17.91	15.10	-45.07	14.35	-9.77	9.64	102.59	12.16	18.57	5.21
% of Revenue	34.43	34.69	33.63	36.22	36.14	37.20	39.00	42.64	43.69	47.54	46.82	45.62	21.79	21.80	19.04	19.77	37.78	39.68	43.27	43.58

Interest Expense
Change (%)
% of Revenue

Net Income	71	75	72	75	42	39	45	54	67	83	99	116	62	71	65	68	143	164	197	209
Change (%)		4.91	-3.68	3.32	-44.24	-5.11	14.13	20.95	22.79	24.15	19.65	16.24	-46.31	15.11	-8.81	4.66	109.54	14.77	20.42	5.73
% of Revenue	60.48	62.97	60.11	58.80	31.16	28.03	29.31	31.97	34.90	38.79	38.76	38.14	17.81	17.93	15.83	15.69	31.01	33.33	36.91	37.36

Source: Capital IQ

Catalyst Pharmaceuticals, Inc. - Laporan Laba Rugi (TTM)

Laporan Laba Rugi (TTM)

Other Listings